Purpose Breast cancer-related lymphedema (BCRL) represents a lifelong risk for breast
cancer survivors and once acquired becomes a lifelong burden. This review summarizes …

Lymphedema affects up to 1 in 6 patients who undergo treatment for a solid tumor in the
United States. Its prevalence has increased as more effective oncologic therapies have …

Breast cancer is the most common cancer diagnosed among women in the Unites States
and globally. 1 The American Cancer Society has estimated that 333,490 new cases of …

Background Lymphedema is one of the most dreaded side effects to any cancer treatment
involving lymphadenectomy. Progressed lymphedema is adversely complex and currently …

Objective To study the safety and tolerability of LymfactinⓇ treatment combined with
microvascular lymph node transfer surgery in patients with upper limb lymphedema …

ABSTRACT BACKGROUND Lymphedema is a common problem after breast cancer
treatment. Lymfactin® is a prolymphangiogenic growth factor vector inducing the expression …

Supermicrosurgery is defined as microsurgery in less than 0.8 mm vessels. It is an evolved
form of microsurgery but with the same principle:(1) enhanced working environment …

Background Recent studies have analyzed the combination of suction‐assisted lipectomy
(SAL) and vascularized lymph node transfer (VLNT) in lymphedema treatment, reporting …

Despite the development of novel pharmacological treatments, cardiovascular disease
morbidity and mortality remain high indicating an unmet clinical need. Viral gene therapy …

Purpose: While vascularized lymph node transplant (VLNT) has gained popularity, there are
a lack of prospective long-term studies and standardized outcomes. The purpose of this …